Stablecoin Development Earnings
NYSE: SDEVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.50-0.0574 (-10.30%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Stablecoin Development earnings summary
In its most recent report on Nov 6, 2026 (Sep/2026), SDEV posted EPS of $0.23. Revenue for the quarter was $2.1 million. Across the last 16 reports, SDEV shares moved an average of 13.3% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
SDEV earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 6, 2026 | — | $0.23 | — | -20.4% |
| Oct 29, 2026 | — | $0.02 | — | -3.0% |
| Jul 30, 2026 | — | $-1.32 | — | -10.4% |
| Apr 6, 2026 | — | $3.33 | — | -3.8% |
| Mar 19, 2026 | — | $-112.86 | — | +29.3% |
| Nov 7, 2025 | — | $-1.10 | — | -2.8% |
| Aug 14, 2025 | — | $-1.65 | — | +46.8% |
| May 15, 2025 | — | $7.08 | — | -3.4% |
| Apr 2, 2025 | — | $7.08 | — | +1.9% |
| Nov 7, 2024 | — | $-1.92 | — | +2.9% |
| Aug 13, 2024 | — | $-1.37 | — | -1.9% |
| May 9, 2024 | — | $-29.95 | — | +50.0% |
| Mar 26, 2024 | — | $-80.75 | — | 0.0% |
| Nov 9, 2023 | — | $-13.11 | — | +3.1% |
| Aug 10, 2023 | — | $-44.43 | — | -11.8% |
| May 11, 2023 | — | $-0.85 | — | -21.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.